Cargando…

Transplantation of human embryonic stem cells alleviates motor dysfunction in AAV2-Htt171-82Q transfected rat model of Huntington’s disease

BACKGROUND: Human embryonic stem cells (hESCs) transplantation had shown to provide a potential source of cells in neurodegenerative disease studies and lead to behavioral recovery in lentivirus transfected or, toxin-induced Huntington's disease (HD) rodent model. Here, we aimed to observe if t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Islam, Jaisan, So, Kyoung Ha, KC, Elina, Moon, Hyeong Cheol, Kim, Aryun, Hyun, Sang Hwan, Kim, Soochong, Park, Young Seok
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607638/ https://www.ncbi.nlm.nih.gov/pubmed/34809707 http://dx.doi.org/10.1186/s13287-021-02653-7

Ejemplares similares

An Optimization of AAV-82Q-Delivered Rat Model of Huntington’s Disease
por: So, Kyoung-Ha, et al.
Publicado: (2020)

Optogenetic stimulation of the motor cortex alleviates neuropathic pain in rats of infraorbital nerve injury with/without CGRP knock-down
por: Islam, Jaisan, et al.
Publicado: (2020)

Stimulating GABAergic Neurons in the Nucleus Accumbens Core Alters the Trigeminal Neuropathic Pain Responses in a Rat Model of Infraorbital Nerve Injury
por: Islam, Jaisan, et al.
Publicado: (2021)

Pain Relief in a Trigeminal Neuralgia Model via Optogenetic Inhibition on Trigeminal Ganglion Itself With Flexible Optic Fiber Cannula
por: KC, Elina, et al.
Publicado: (2022)

HTT haplogroups in Finnish patients with Huntington disease
por: Ylönen, Susanna, et al.
Publicado: (2019)

Intrastriatal Administration of AAV5-miHTT in Non-Human Primates and Rats Is Well Tolerated and Results in miHTT Transgene Expression in Key Areas of Huntington Disease Pathology
por: Spronck, Elisabeth A., et al.
Publicado: (2021)

Modulation of trigeminal neuropathic pain by optogenetic inhibition of posterior hypothalamus in CCI-ION rat
por: Islam, Jaisan, et al.
Publicado: (2023)

AAV5-miHTT Gene Therapy Demonstrates Sustained Huntingtin Lowering and Functional Improvement in Huntington Disease Mouse Models
por: Spronck, Elisabeth A., et al.
Publicado: (2019)

AAV5-miHTT gene therapy demonstrates suppression of mutant huntingtin aggregation and neuronal dysfunction in a rat model of Huntington’s disease
por: Miniarikova, J, et al.
Publicado: (2017)

Iron activates microglia and directly stimulates indoleamine-2,3-dioxygenase activity in the N171-82Q mouse model of Huntington’s disease
por: Donley, David W., et al.
Publicado: (2021)

Beneficial behavioral effects of chronic cerebral dopamine neurotrophic factor (CDNF) infusion in the N171-82Q transgenic model of Huntington’s disease
por: Stepanova, P., et al.
Publicado: (2023)

Parkinsonism with a Hint of Huntington’s from 29 CAG Repeats in HTT
por: JOT, Sipilä
Publicado: (2019)

AAV5-miHTT Gene Therapy Demonstrates Broad Distribution and Strong Human Mutant Huntingtin Lowering in a Huntington’s Disease Minipig Model
por: Evers, Melvin M., et al.
Publicado: (2018)

Pain modulation effect on motor cortex after optogenetic stimulation in shPKCγ knockdown dorsal root ganglion-compressed Sprague-Dawley rat model
por: Islam, Jaisan, et al.
Publicado: (2020)

Activation of CamKIIα expressing neurons on ventrolateral periaqueductal gray improves behavioral hypersensitivity and thalamic discharge in a trigeminal neuralgia rat model
por: Elina, K. C., et al.
Publicado: (2021)

Huntington’s Disease—An Outlook on the Interplay of the HTT Protein, Microtubules and Actin Cytoskeletal Components
por: Taran, Aleksandra S., et al.
Publicado: (2020)

In silico designing of putative peptides for targeting pathological protein Htt in Huntington's disease
por: Kohli, Harleen, et al.
Publicado: (2021)

A novel and accurate full-length HTT mouse model for Huntington’s disease
por: Shenoy, Sushila A, et al.
Publicado: (2022)

Alternative processing of human HTT mRNA with implications for Huntington’s disease therapeutics
por: Fienko, Sandra, et al.
Publicado: (2022)

Functional Characterisation of the Circular RNA, circHTT(2-6), in Huntington’s Disease
por: Gantley, Laura, et al.
Publicado: (2023)

Effects of the Pimelic Diphenylamide Histone Deacetylase Inhibitor HDACi 4b on the R6/2 and N171-82Q Mouse Models of Huntington’s Disease
por: Chen, Jane Y., et al.
Publicado: (2013)

FAN1 modifies Huntington’s disease progression by stabilizing the expanded HTT CAG repeat
por: Goold, Robert, et al.
Publicado: (2019)

The pathogenic exon 1 HTT protein is produced by incomplete splicing in Huntington’s disease patients
por: Neueder, Andreas, et al.
Publicado: (2017)

Correction: Effects of the Pimelic Diphenylamide Histone Deacetylase Inhibitor HDACi 4b on the R6/2 and N171-82Q Mouse Models of Huntington’s Disease
Publicado: (2017)

Adeno-Associated Viral Vector Serotype DJ-Mediated Overexpression of N171-82Q-Mutant Huntingtin in the Striatum of Juvenile Mice Is a New Model for Huntington’s Disease
por: Jang, Minhee, et al.
Publicado: (2018)

Targeting Gpr52 lowers mutant HTT levels and rescues Huntington’s disease-associated phenotypes
por: Song, Haikun, et al.
Publicado: (2018)

Integrated analysis on transcriptome and behaviors defines HTT repeat-dependent network modules in Huntington's disease
por: Huang, Lulin, et al.
Publicado: (2021)

GPR171 Activation Modulates Nociceptor Functions, Alleviating Pathologic Pain
por: Cho, Pyung Sun, et al.
Publicado: (2021)

Frequency of the loss of CAA interruption in the HTT CAG tract and implications for Huntington disease in the reduced penetrance range
por: Findlay Black, Hailey, et al.
Publicado: (2020)

An alternative splicing modulator decreases mutant HTT and improves the molecular fingerprint in Huntington’s disease patient neurons
por: Krach, Florian, et al.
Publicado: (2022)

GFAP-NpHR mediated optogenetic inhibition of trigeminal nucleus caudalis attenuates hypersensitive behaviors and thalamic discharge attributed to infraorbital nerve constriction injury
por: KC, Elina, et al.
Publicado: (2023)

Trigeminal ganglion itself can be a viable target to manage trigeminal neuralgia
por: KC, Elina, et al.
Publicado: (2022)

Developmental Trajectory of Height, Weight, and BMI in Children and Adolescents at Risk for Huntington’s Disease: Effect of mHTT on Growth
por: Tereshchenko, Alexander, et al.
Publicado: (2020)

Htt(Q111/+) Huntington’s Disease Knock-in Mice Exhibit Brain Region-Specific Morphological Changes and Synaptic Dysfunction
por: Kovalenko, Marina, et al.
Publicado: (2018)

Spanish HTT gene study reveals haplotype and allelic diversity with possible implications for germline expansion dynamics in Huntington disease
por: Ruiz de Sabando, Ainara, et al.
Publicado: (2022)

Identification of a HTT-specific binding motif in DNAJB1 essential for suppression and disaggregation of HTT
por: Ayala Mariscal, S. M., et al.
Publicado: (2022)

Excess Rab4 rescues synaptic and behavioral dysfunction caused by defective HTT-Rab4 axonal transport in Huntington’s disease
por: White, Joseph A., et al.
Publicado: (2020)

Goody two plasmids: An optimized transient transfection system for AAV vector production
por: Moreno Velasquez, Sergio David, et al.
Publicado: (2023)

HTT-DB: new features and updates
por: Dotto, Bruno Reis, et al.
Publicado: (2018)

Motivational, proteostatic and transcriptional deficits precede synapse loss, gliosis and neurodegeneration in the B6.Htt(Q111/+) model of Huntington’s disease
por: Bragg, Robert M., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ijhstue8pg9ccm34tc5406kfcq